Treatment of neuroendocrine tumours with infusional 5-fluorouracil, folinic acid and streptozocin

26Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A standardised, effective systemic therapy for metastatic neuroendocrine tumours (NETs) has not been established to date. We reviewed the management of 15 patients with inoperable, metastatic NET treated systematically with a combination chemotherapy regimen of infusional 5-fluorouracil, folinic acid and streptozocin. Overall objective response rate was 53% and tolerability was excellent. © 2003 Cancer Research UK.

Cite

CITATION STYLE

APA

Gonzalez, M. A., Biswas, S., Clifton, L., & Corrie, P. G. (2003). Treatment of neuroendocrine tumours with infusional 5-fluorouracil, folinic acid and streptozocin. British Journal of Cancer, 89(3), 455–456. https://doi.org/10.1038/sj.bjc.6601167

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free